Prevalence and Characteristics of Adrenal Tumors in an Unselected Screening Population : A Cross-Sectional Study
- PMID: 36095315
- DOI: 10.7326/M22-1619
Prevalence and Characteristics of Adrenal Tumors in an Unselected Screening Population : A Cross-Sectional Study
Abstract
Background: With the widespread use of advanced imaging technology, adrenal tumors are increasingly being identified.
Objective: To investigate the prevalence and characteristics of adrenal tumors in an unselected screening population in China.
Design: Cross-sectional study. (ClinicalTrials.gov: NCT04682938).
Setting: A health examination center in China.
Patients: Adults having an annual checkup were invited to be screened for adrenal tumors by adrenal computed tomography.
Measurements: The participants with adrenal tumors had further evaluation for malignancy risk and adrenal function.
Results: A total of 25 356 participants were screened, 351 of whom were found to have adrenal tumors, for a prevalence of 1.4%. The prevalence increased with age, from 0.2% in participants aged 18 to 25 years to 3.2% in those older than 65 years. Among 351 participants with adrenal tumors, 337 were diagnosed with an adrenocortical adenoma, 14 with another benign nodule, and none with a malignant mass. In 212 participants with an adenoma who completed endocrine testing, 69.3% were diagnosed with a nonfunctioning adenoma, 18.9% with cortisol autonomy, 11.8% with primary aldosteronism, and none with pheochromocytoma. Proportions of nonfunctioning adenomas were similarly high in various age groups (72.2%, 67.8%, and 72.2% in those aged <46, 46 to 65, and ≥66 years, respectively).
Limitation: Only 212 of 337 participants with an adrenocortical adenoma had endocrine testing.
Conclusion: The prevalence of adrenal tumors in the general adult screening population is 1.4%, and most of these tumors are nonfunctioning regardless of patient age. Cortisol and aldosterone secretion are the main causes of functional adenomas.
Primary funding source: National Key Research and Development Program of China and National Natural Science Foundation of China.
Comment in
-
Adrenal Incidentalomas: Insights Into Prevalence.Ann Intern Med. 2022 Oct;175(10):1481-1482. doi: 10.7326/M22-2600. Epub 2022 Sep 13. Ann Intern Med. 2022. PMID: 36095311 No abstract available.
Similar articles
-
A nationwide survey of adrenal incidentalomas in Japan: the first report of clinical and epidemiological features.Endocr J. 2020 Feb 28;67(2):141-152. doi: 10.1507/endocrj.EJ18-0486. Epub 2019 Nov 7. Endocr J. 2020. PMID: 31694993
-
Functional Characterization of Adrenocortical Masses in Nononcologic Patients Using 68Ga-Pentixafor.J Nucl Med. 2022 Mar;63(3):368-375. doi: 10.2967/jnumed.121.261964. Epub 2021 Jul 22. J Nucl Med. 2022. PMID: 34301781 Free PMC article.
-
Incidentally discovered adrenal tumors: endocrine and scintigraphic correlates.J Clin Endocrinol Metab. 1998 Jan;83(1):55-62. doi: 10.1210/jcem.83.1.4501. J Clin Endocrinol Metab. 1998. PMID: 9435416
-
Overview of the 2022 WHO Classification of Adrenal Cortical Tumors.Endocr Pathol. 2022 Mar;33(1):155-196. doi: 10.1007/s12022-022-09710-8. Epub 2022 Mar 14. Endocr Pathol. 2022. PMID: 35288842 Free PMC article. Review.
-
[Nonfunctioning adrenocortical adenoma: a report of two cases].Hinyokika Kiyo. 1989 Jul;35(7):1167-72. Hinyokika Kiyo. 1989. PMID: 2678981 Review. Japanese.
Cited by
-
Analysis of characteristics of four patients with adrenal unicentric Castleman disease.Front Endocrinol (Lausanne). 2023 May 17;14:1181929. doi: 10.3389/fendo.2023.1181929. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37265694 Free PMC article.
-
Evaluation of Serum Neudesin Levels in Patients With Adrenal Incidentaloma.Cureus. 2025 Jun 13;17(6):e85968. doi: 10.7759/cureus.85968. eCollection 2025 Jun. Cureus. 2025. PMID: 40662017 Free PMC article.
-
Retroperitoneoscopic enucleation adrenalectomy: a viable surgical option for small nonsecreting adrenal tumors with low potential of malignancy.Transl Androl Urol. 2023 Nov 30;12(11):1713-1722. doi: 10.21037/tau-23-54. Epub 2023 Nov 16. Transl Androl Urol. 2023. PMID: 38106691 Free PMC article.
-
Ablation and laparoscopic adrenalectomy: Balancing efficacy and safety in the treatment of benign adrenal gland tumors: A systematic review and meta-analysis.Heliyon. 2024 Sep 12;10(19):e37868. doi: 10.1016/j.heliyon.2024.e37868. eCollection 2024 Oct 15. Heliyon. 2024. PMID: 39386870 Free PMC article.
-
[Adrenal tumors: current standards in clinical management].Inn Med (Heidelb). 2024 Jul;65(7):632-641. doi: 10.1007/s00108-024-01727-x. Epub 2024 Jun 12. Inn Med (Heidelb). 2024. PMID: 38864873 German.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Medical